News and Announcements
Muoverti kickstarts its latest fundraising round with the lead investment from Ganash Invest B.V.
- Published August 18, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
“Muoverti’s TiltBike makes virtual indoor sessions feel like real rides. Clip in and conquer the
Metaverse.” – Men’s Health
“The idea of a much more integrated, much more realistic indoor experience touched all the right buttons for me. I think that adds together to be a very compelling proposition.” – David Stroud
Muoverti is a pioneering sports tech business, on a mission to build the world’s best at-home cycling experience for sport cyclists and multi-sport athletes. Unlike current options, TiltBikes feel more natural for the body – like riding a bike outdoors – and enable immersive simulations for essential training, esports, and interactive fitness. The TiltBike and its connected online applications enable new, immersive media experiences, from structured plans to e-sports and interactive gaming.
After enthusiastic public reception Muoverti now has 10x more people on the waitlist than they currently have capacity. Muoverti closed £1.64M Seed earlier this year and has just signed £500K of lead investment by Ganash Invest B.V., Amsterdam for this next fundraising round. The company is now looking to fill the additional headroom through convertibles that benefit from a 20% discount on the share price of the next round if signed by September 31st. Get in touch to join the ride!
Muoverti was founded by entrepreneurs Christoph Wilfert and Alex Caccia, also the original founder of WaterRower. Muoverti is based in London, UK.
Company Updates
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
